2023, Number 2
Respiratory causes of death in Mexico 2021
Full text
10.35366/115394
Language: English/Spanish [Versi?n en espa?ol]
References: 13
Page: 79-83
PDF size: 234.58 Kb.
ABSTRACT
Introduction: in the international classification of diseases (ICD-10), deaths of primary respiratory origin are scattered across several sections, uncommonly compiled together as often happens with neoplasias and cardiovascular deaths, leading to underestimation of the impact of respiratory diseases and the influx of resources to the patients. Material and methods: mortality statistics for Mexico for 2021 coded with the ICD-10 were reviewed. All causes of death, primarily respiratory, were added, both from section J, and from those distributed in other sections, and compared against those that occurred in 2015. Results: in 2015, 79,383 respiratory deaths (12.6% of the total) were coded, of which 54,173 were in the respiratory "J" codes and the rest (25,210) in other codes, while in 2021 there were 349,491 (31% of the total), an impressive increase due to the COVID-19 pandemic. The most common causes of death were COPD, pneumonia-influenza, malignant tumors of the chest, neonatal respiratory deaths, disorders of the pulmonary circulation, interstitial diseases, asthma, and tuberculosis. Conclusions: respiratory diseases are an important cause of death in Mexico with and without respiratory pandemic, so the appropriate training of personnel and granting sufficient resources to care for the sick must be supported.INTRODUCTION
Respiratory diseases are a primary cause of mortality and morbidity in the world,1 much more remarkable once acute and chronic causes are added, as well as infectious and non-infectious ones. This fact can be intuited by observing that, worldwide, several respiratory diseases appear in the first 10 causes of disease and death, chronic obstructive pulmonary disease (COPD) is the third cause of death.2
In the current International Classification of Diseases (ICD-10) the main acute and chronic respiratory diseases of the entire respiratory tract and chest are in section "J";3 however, many others are classified in other sections.2 The objective of this work, an update of the one carried out in 2015,4 is to describe the main causes of respiratory death in Mexico in 2021 and compare them with those of 2015. This description is important, since the causes of respiratory origin are scattered throughout several chapters of the ICD-10, and at the national and international level there is an underestimation of the importance of respiratory diseases that can decrease awareness about them in general and especially about chronic diseases, this in turn can lead to a scarce budget allocation and poor patient care, in addition to a decreased influx of people interested in training in respiratory diseases at least in some countries, who maybe deficient in qualified personnel to care for them.
MATERIAL AND METHODS
For this work, the mortality statistics of Mexico in 2021, codified with the tenth edition of the International Classification of Diseases (ICD-10),3 were analyzed. Those of 2015 were taken from the World Health Organization (WHO) website, which are the statistics that each country reports and were the reason for a previous study.4 As ICD-10 incorporates in its latest versions thousands of diagnostic codes and procedures, we use clinical classification software (CCS) that reduces the diagnostic codes to 285 mutually exclusive (Table 1)5 and additionally according to the scheme of Becker and collaborators6 that reduces them to less than 100, in order to describe in a standardized way the main certified causes of death that include a classifiable cause. Subsequently, all causes of death of respiratory origin classified within any chapter of ICD-102 were grouped, including those within and outside respiratory group "J".
RESULTS
Table 1 shows the respiratory deaths coded outside group J (25,210) and those within group J (54,173), for a total of 79,383 deaths of respiratory origin in 2015, of which approximately one third were classified outside section J. In 2021, respiratory deaths totaled 349,491 (31% of the total). These grouped totals are calculated in the same way, summing scattered causes in different chapters of the classification and, therefore, have overlapping codes. For example, respiratory cancers appear in the total of respiratory deaths and in the total of cancer deaths, and pulmonary vascular diseases appear in both respiratory and cardiovascular diseases. Table 2 describes the main causes of death in Mexico according to clinical classification software (CCS)5 with mutually exclusive groupings.
DISCUSSION
The results described highlight the importance in Mexico of respiratory diseases, much more notable in 2021 due to the COVID-19 pandemic, a primarily respiratory disease. While recognizing that SARS-CoV-2 generates multi-system complications especially in the so-called prolonged COVID, the main cause of death is respiratory failure. In addition, the respiratory ailments, frequent and not, that caused certified deaths in Mexico are described. This information is important for planning services and training respiratory disease experts. Except for COVID-19, the distribution in 2015 and 2021 is similar with the exception of some codes that increased in 2021 substantially compared to 2015, but which may be contaminated by the COVID-19 pandemic such as influenza and pneumonia, respiratory failure, and acute respiratory distress syndrome (ARDS) (Table 1).
Several groups of diseases that would need to be reinforced in assistance and training programs for adults and children draw attention. In adults are notable cor pulmonale, pulmonary arterial hypertension, diseases of the pulmonary vasculature and the obesity syndrome hypoventilation and sleep apnea, which already causes significant morbidity and is growing in proportion to obesity. They also highlight benign and malignant chest tumors, HIV respiratory complications, and acute and chronic respiratory failure. But without a doubt, COPD, pneumonia and influenza cause the majority of respiratory deaths.
In general, respiratory diseases, especially chronic ones, are under diagnosed and under treated, while a growing increase in their causal factors can be demonstrated: smoking, exposure to polluted air, overcrowding, survival of premature children with bronchopulmonary dysplasia, population aging and the persistence of other factors such as poverty, the use of solid fuels and limited access to health services.
The determinants of the minimization of respiratory diseases are undoubtedly several, and include the efficient management of groups interested in other diseases, which can contribute to the heterogeneous way of classifying deaths, since some codes are derived from etiology, while others are based on pathophysiological mechanisms, and others are classified by affected organ or system.
This heterogeneous way of classifying weakens the position of specialists focused on an apparatus or system, such as the respiratory system, whose causes of death are broken down into several sections of the ICD-10.2 For example, perinatal respiratory problems and those related to pregnancy, childbirth and the puerperium are classified separately from group J, which helps to highlight the significant health risk posed by the reproductive phenomenon, especially in some regions. The same applies to respiratory complications of rheumatic diseases and those of external agents.
However, this strategy is done at the expense of diluting the relevance of the respiratory system as an organ of shock and in a health system that competes for limited and fixed resources, whether economic or human, it can be disadvantageous for the adequate care of respiratory diseases, especially those that lack well-defined etiological agents, or when they are multiple, as well as for having personnel trained in these diseases. It is still contradictory from the historical point of view for the respiratory specialty that tuberculosis, the origin of pneumology, is classified outside the respiratory group and within infectious diseases, very correct by etiological agent, but excluded from the respiratory group. From a practical point of view, the classification by etiology, and not by organ or system, or by altered function, or as it originally occurred, by symptoms or syndrome, is the most recent and advanced, and allows to identify preventive measures. However, we have examples where having an etiological agent, such as smoking, with multiple consequences and damaged organs, a group based on a relatively non-specific functional alteration is maintained, such as chronic obstruction to the passage of air, which immediately calls for intervention with bronchodilators, but not with measures to stop smoking, the main cause in almost everyone.
The data shown have known limitations, since they are based on death certificates7 and on using, in general, only one cause of death and not several described in the certificate.8-10 When multiple causes of death are used, an even greater increase in the contribution of respiratory diseases is expected than that described in this work using only one.10-12 But similar results are obtained from widely used estimates based on disease models and risk factors, such as those of the Global Burden of Diseases1 information with which an analysis of the health situation in Mexico was made.13
CONCLUSION
In addition to mortality, it is important to consider other health indicators, such as the disease itself, disability and the use of health services that undoubtedly contribute to the burden of disease in a country. Within respiratory diseases, asthma and several diseases of the upper airway generate a considerable burden of disability and care services, but on the other hand the impact on deaths is limited, although relevant since they are considered preventable deaths (Table 1).
REFERENCES
Soriano JB, Kendrick PJ, Paulson KR, Gupta V, Abrams EM, et al.; GBD Chronic Respiratory Disease Collaborators. Prevalence and attributable health burden of chronic respiratory diseases, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet Respir Med. 2020;8(6):585-596. doi: 10.1016/s2213-2600(20)30105-3.
AFFILIATIONS
1Instituto Nacional de Enfermedades Respiratoria Ismael Cosío Villegas. Mexico City, Mexico.
Conflict of interests: the author declares that he has no conflict of interests.
CORRESPONDENCE
Dr. José Rogelio Pérez-Padilla. E-mail: perezpad@gmail.comReceived: X-21-2023; accepted: XI-15-2023.